Navigation Links
XEOMIN® (incobotulinumtoxinA) Data to be Presented at the 72nd Annual Assembly of the American Academy of Physical Medicine and Rehabilitation
Date:11/17/2011

nd an investigator for XEOMIN®. "Merz has established a positive presence in the movement disorder community and XEOMIN® continues to provide value for patients and doctors."

XEOMIN® is approved in 20 countries for the treatment of blepharospasm, in 21 countries for the treatment of cervical dystonia (also known as spasmodic torticollis), and in 17 countries for post-stroke spasticity of the upper limb. XEOMIN® is not approved for the treatment of spasticity in the U.S.

The results of an additional study evaluating the safety and efficacy of XEOMIN® in the treatment of cervical dystonia when administered at flexible dosing regimens, as well as data showing the safety and efficacy of XEOMIN® in the treatment of UL post-stroke spasticity, will also be presented:

  • Poster 129: Sustained efficacy with incobotulinumtoxinA (XEOMIN®; botulinum neurotoxin type A, free from accessory proteins) for up to 89 weeks in upper limb post-stroke spasticity (Kanovsky, et al.)
  • Poster 131: IncobotulinumtoxinA (XEOMIN®; botulinum neurotoxin type A, free from accessory proteins): Flexibility of dosing and injection intervals in cervical dystonia (Evidente, et al.)

About XEOMIN®

Botulinum toxin type A is naturally produced by Clostridium botulinum as a larger protein complex containing therapeutically unnecessary accessory or complexing proteins.

XEOMIN® (incobotulinumtoxinA) is manufactured using an FDA-approved state-of-the-art biotechnological process, which yields the pure neurotoxin with a low foreign protein content. Foreign proteins are considered as one of the factors for secondary therapy failure.

Since its launch in 2005, more than 261,000 patients have been treated with XEOMIN® worldwide. It is approved in 20 countries for the treatment o
'/>"/>

SOURCE Merz Pharmaceuticals GmbH
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Data on Xeomin® (incobotulinumtoxinA) in the Treatment of Blepharospasm to be Presented at the 115th Annual Meeting of the American Academy of Ophthalmology
2. New Data On Xeomin® (IncobotulinumtoxinA) To Be Presented At The 15th International Congress Of Parkinsons Disease And Movement Disorders (MDS)
3. Merz Pharmaceuticals Announces New Centers for Medicare and Medicaid Billing Q-Code for Xeomin® (incobotulinumtoxinA)
4. Merz Pharmaceuticals Introduces Comprehensive Programs to Provide Patients With Financial Assistance for Xeomin® (incobotulinumtoxinA)
5. Xeomin® (incobotulinumtoxinA) Data To Be Presented At The 71st Annual Assembly Of The American Academy Of Physical Medicine And Rehabilitation
6. Xeomin® (incobotulinumtoxinA) - a Botulinum Toxin Free From Accessory Proteins - Now Available in the U.S.
7. FDA Approves Merz Pharmaceuticals Xeomin® (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm
8. New Analysis of Data Presented at AHA Regarding Effect of Effient® (Prasugrel) on Cardiovascular Events in STEMI Patients According to Timing of PCI
9. Abbott Statement on the Results of the AIM-HIGH Study Presented at AHA 2011
10. Positive Results from Phase 2 Trial of Mesoblasts Adult Stem Cell Therapy Presented at the American Heart Association Annual Meeting
11. Multiple Programs from Merrimack Pharmaceuticals Pipeline to be Presented at the 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... KOPENHAGEN, Dänemark, 30. Juni 2015 ... der klinischen und kommerziellen Produktion von monoklonalen ... bekannt, dass das Unternehmen im Rahmen seiner ... nordamerikanischen Produktionsanlage in Bothell, Washington ... Bioreactor 6Pack™ komplettiert hat. Die Konfiguration Bioreactor ...
(Date:6/30/2015)... June 30, 2015  Marken, the leading clinical trial ... sciences industry, has been granted permission by the government ... clinical drug product in Korea.  This precedent-setting shipment has ... to continue receiving their clinical trial drugs during ... The emergency was caused by recent partial closures ...
(Date:6/30/2015)... PharmaVentures is pleased to announce ... Oy (CMT) on its divestment of certain assets to ... world leading capabilities in cellular imaging and analysis. ... of successful global deals in the life science research ... Walton , CEO, PharmaVentures, commented: "PharmaVentures is delighted to ...
Breaking Medicine Technology:CMC Biologics baut GMP-Produktionskapazität in den USA aus 2CMC Biologics baut GMP-Produktionskapazität in den USA aus 3Marken Delivers Direct To Patients During MERS Outbreak 2Marken Delivers Direct To Patients During MERS Outbreak 3PharmaVentures Completes M&A Deal for Technology in the Stem Cell & Regenerative Medicine Sector 2
... Perrigo Company today announced that it will attend the ... Asthma & Immunology Conference (ACAAI) Nov. 3-8 at the ... Boston. The ACAAI is a professional ... the medical subspecialty of allergy and immunology.  It is ...
... The oncology market continues to be a rapid ... aspects of successfully launching a new oncology product is ... Strategic Marketing function. The regulatory environment, ... marketplace present significant challenges for Global Strategic Marketing (GSM) ...
Cached Medicine Technology:Perrigo Company to Attend the 2011 Annual Meeting of the American College of Allergy, Asthma & Immunology 2Perrigo Company to Attend the 2011 Annual Meeting of the American College of Allergy, Asthma & Immunology 3Global Strategic Marketing Key to Success in Oncology Launches in the Pharmaceutical Sector 2
(Date:6/30/2015)... ... 30, 2015 , ... Broadway by the Sea posted its newest YouTube video ... testimonials. Medicare rated the care center as a five-star location based on a comprehensive ... future patients a firsthand look at the facility’s satisfied residents. , “In this ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... eyeglasses online , finally its here, http://www.express-glasses.com is proud to ... for many location, ask about shipping with DHL Express when calling or visiting ...
(Date:6/30/2015)... , ... June 30, 2015 , ... ... currently pending in a federal multidistrict litigation now underway in the U.S. District ... next monthly Status Conference. According to the Court’s calendar, that conference has now ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... Rocky Mountain ... has restructured its management team and added a new CEO, Mr. Darold Francis. The ... leading selection of premium essential oils that customers have come to know and respect ...
(Date:6/30/2015)... ... June 30, 2015 , ... Allied Anesthesia physicians are committed ... volunteered to help provide free outpatient procedures to some of Orange County’s neediest ... Medical Center. , The event was coordinated by AccessOC, which was founded ...
Breaking Medicine News(10 mins):Health News:Broadway by the Sea Video Promotes Top Quality Service 2Health News:Eyeglasses Online - Express Glasses Announcing New International Shipping Using DHL 2Health News:Progress of Federal Xarelto Lawsuits Pending in Multidistrict Litigation to Be Discussed During July 9th Status Conference 2Health News:Progress of Federal Xarelto Lawsuits Pending in Multidistrict Litigation to Be Discussed During July 9th Status Conference 3Health News:Rocky Mountain Oils Adds New CEO, Announces Relocation of Operations to Orem, Utah 2Health News:Allied Anesthesia Physicians Volunteer to Help Orange County’s Uninsured During Annual Super Surgery Saturday 2Health News:Allied Anesthesia Physicians Volunteer to Help Orange County’s Uninsured During Annual Super Surgery Saturday 3
... ... a large pill. Impact Nutritionals, Inc. launches its first product, S7 Prenatal™ Drink Mix, the ... premise that supplements should taste good and be good for you. To celebrate the launch, ... , ...
... ... crisis largely due to the failure of highly profitable miracle drugs which ... article, The Perfect Health Plan: Proven, Safe, Effective, and Inexpensive, research scientist ... these FDA approved, properly prescribed, and properly administered miracle drugs. He explains ...
... (July 27, 2009) Government health officials from 13 ... of the continent,s medical laboratories, starting a process that ... believe will be an historic step to strengthen health ... Just a handful of Africa,s laboratories are now accredited, ...
... may someday lead to a cure, studies suggest , SUNDAY, ... solving a medical mystery with huge implications for personal and ... 2 diabetes. , A series of studies appearing online July ... the fat tissues of heavy individuals could trigger the blood ...
... , , , ... ARAY ), a global leader in the field of radiosurgery, announced ... real-time customer service and support offering for the CyberKnife((R)) Robotic Radiosurgery ... 51st Annual Meeting of The American Association of Physicists in Medicine, ...
... , , , LOS ANGELES ... Kaiser Permanente hospitals nationwide voted overwhelmingly today to ratify their first-ever ... -- which is contracted by Kaiser to protect its facilities -- ... , , "This is a great ...
Cached Medicine News:Health News:Moms, Registered Dietitian, Develop the First All-In-One Prenatal Vitamin in a Great Tasting Drink Mix 2Health News:Research Scientist Reports On Time-Tested Solution To Current Medical Crisis 2Health News:Research Scientist Reports On Time-Tested Solution To Current Medical Crisis 3Health News:Research Scientist Reports On Time-Tested Solution To Current Medical Crisis 4Health News:Leading health organizations launch new accreditation process for laboratories across Africa 2Health News:Leading health organizations launch new accreditation process for laboratories across Africa 3Health News:Leading health organizations launch new accreditation process for laboratories across Africa 4Health News:Unhooking the Obesity-Diabetes Connection 2Health News:Unhooking the Obesity-Diabetes Connection 3Health News:Accuray Announces CyberKnife Access Remote Service Product 2Health News:Accuray Announces CyberKnife Access Remote Service Product 3Health News:Accuray Announces CyberKnife Access Remote Service Product 4Health News:SEIU Security Officers Who Protect Kaiser Permanente Hospitals Nationwide Vote Overwhelmingly to Ratify First-Ever Union Contract 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: